BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 598566)

  • 1. Inhibition of L-dopa induced growth hormone release in normal and diabetic subjects by glucose administration.
    Vigas M; Klimes I; Jurcovicova J; Kolesar P; Repcekova-Jezova D
    Diabete Metab; 1977 Dec; 3(4):257-8. PubMed ID: 598566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRH-induced growth hormone release in insulin-dependent diabetes mellitus.
    Krassowski J; Jeske W; Zgliczyński S
    Horm Metab Res; 1984 Dec; 16 Suppl 1():119-22. PubMed ID: 6442706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of l-dopa on growth hormone, glucose, insulin, and cortisol response in obese subjects.
    Vizner B; Reiner Z; Sekso M
    Exp Clin Endocrinol; 1983 Jan; 81(1):41-8. PubMed ID: 6343098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hyperglycemia on the growth hormone response to L-dopa in diabetic subjects.
    Barbarino A; De Marinis L; Martino F
    J Endocrinol Invest; 1978 Jul; 1(3):259-61. PubMed ID: 756876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of somatostatin on the rise of growth hormone and glucagon secretion induced by arginine and L-dopa in diabetic patients.
    Hansen AP; Christensen SE; Lundbaek K
    Scand J Clin Lab Invest; 1975 May; 35(3):205-10. PubMed ID: 1153917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of sustained hyperglycemia on GHRH induced GH secretion in man.
    Garrel DR; Bajard L; Harfouche M; Tourniaire J
    Diabete Metab; 1989; 15(5):251-4. PubMed ID: 2517116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on growth hormone and prolactin secretions in myotonic dystrophy.
    Canal N; Smirne S; Comi G; Guidobono F; Pecile A; Caviezel F
    Acta Neurol Belg; 1982; 82(3):178-84. PubMed ID: 7051737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does gonadotropin-releasing hormone administration affect serum growth hormone levels in poorly controlled insulin-dependent and non-insulin-dependent diabetes mellitus?
    Gürlek A; Yordam N; Telatar F
    Isr J Med Sci; 1995 Nov; 31(11):685-9. PubMed ID: 7591703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of glucose on the glucagon response to L-dopa in normal and diabetic subjects.
    Klimes I; Vigas M; Jurcovicová J; Repceková D; Kolesár P
    Diabetes; 1978 Apr; 27(4):396-9. PubMed ID: 640244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal growth hormone responsiveness to stimuli in women with active celiac sprue.
    Peracchi M; Molteni N; Cantalamessa L; Bardella MT; Peracchi G; Orsatti A; Faggioli P; Bianchi PA
    Am J Gastroenterol; 1992 May; 87(5):580-3. PubMed ID: 1595643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arginine abolishes the inhibitory effect of glucose on the growth hormone response to growth hormone-releasing hormone in man.
    Ghigo E; Miola C; Aimaretti G; Valente F; Procopio M; Arvat E; Yin-Zhang W; Camanni F
    Metabolism; 1992 Sep; 41(9):1000-3. PubMed ID: 1355580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of growth hormone releasing hormone on growth hormone, prostaglandin E2 and insulin in non-insulin-dependent diabetic patients.
    Koev D; Zacharieva S; Popova J; Andonova K
    Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):137-40. PubMed ID: 8740245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of L-dopa-induced growth hormone stimulation by pyridoxine and chlorpromazine.
    Mims RB; Scott CL; Modebe O; Bethune JE
    J Clin Endocrinol Metab; 1975 Feb; 40(2):256-9. PubMed ID: 1117978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of L-dopa administration on insulin binding: possible role of growth hormone in regulation of insulin receptor affinity.
    Iwasaki M; Kobayashi M; Ohgaku S; Maegawa H; Shigeta Y
    Horm Metab Res; 1982 Jul; 14(7):342-5. PubMed ID: 6749630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of glucose on the growth hormone response to L-dopa in normal and diabetic subjects.
    Ajlouni K; Martinson DR; Hagen TC
    Diabetes; 1975 Jul; 24(7):633-6. PubMed ID: 1158029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of acute hypercalcaemia on arginine induced growth hormone release in diabetic man.
    Kaplan PW; Jung RT
    Horm Metab Res; 1984 Dec; 16 Suppl 1():123-6. PubMed ID: 6532933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Method of determination of somatotropin level in blood plasma with L-dopa loading in patients with diabetes mellitus complicated by microangiopathies].
    Babakhanov KhB
    Lab Delo; 1975; (10):605-7. PubMed ID: 54462
    [No Abstract]   [Full Text] [Related]  

  • 18. [A low response of pituitary growth hormone secretion in the patient with diabetes mellitus after intravenous administration of L-dopa (author's transl)].
    Shimoda S; Takemura Y; Ieiri T; Kasai K; Kikuchi T
    Nihon Naibunpi Gakkai Zasshi; 1975 Jan; 51(1):9-17. PubMed ID: 1171032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinergic receptor control mechanisms for L-dopa, apomorphine, and clonidine-induced growth hormone secretion in man.
    Delitala G; Maioli M; Pacifico A; Brianda S; Palermo M; Mannelli M
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1145-9. PubMed ID: 6688812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the mechanism of hyperglycemia and stimulation of growth hormone secretion by L-dopa.
    Hampshire J; Moraru E; Altszuler N
    Pharmacology; 1978; 17(3):138-48. PubMed ID: 704657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.